Kodela R[au] - Search Results

Year	Number of Results
2009	1
2010	3
2011	5
2012	5
2013	4
2015	7
2016	1
2020	1
2022	0

1

NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS.

Chattopadhyay M, Kodela R, Santiago G, Le TTC, Nath N, Kashfi K. Chattopadhyay M, et al. Among authors: kodela r. Biochem Pharmacol. 2020 Jun;176:113857. doi: 10.1016/j.bcp.2020.113857. Epub 2020 Feb 14. Biochem Pharmacol. 2020. PMID: 32061771 Free PMC article.

2

NOSH-Aspirin Inhibits Colon Cancer Cell Growth: Effects Of Positional Isomerism.

Vannini F, Kodela R, Chattopadhyay M, Kashfi K. Vannini F, et al. Among authors: kodela r. Redox Biol. 2015 Aug;5:421. doi: 10.1016/j.redox.2015.09.033. Epub 2015 Dec 30. Redox Biol. 2015. PMID: 28162291 Free article.

3

Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression.

Chattopadhyay M, Nath N, Kodela R, Sobocki T, Metkar S, Gan ZY, Kashfi K. Chattopadhyay M, et al. Among authors: kodela r. Leuk Res. 2013 Oct;37(10):1302-8. doi: 10.1016/j.leukres.2013.07.004. Epub 2013 Jul 26. Leuk Res. 2013. PMID: 23896061 Free PMC article.

4

NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals.

Kodela R, Chattopadhyay M, Kashfi K. Kodela R, et al. ACS Med Chem Lett. 2012 Mar 8;3(3):257-262. doi: 10.1021/ml300002m. Epub 2012 Jan 28. ACS Med Chem Lett. 2012. PMID: 22916316 Free PMC article.

5

Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling.

Kodela R, Nath N, Chattopadhyay M, Nesbitt DE, Velázquez-Martínez CA, Kashfi K. Kodela R, et al. Drug Des Devel Ther. 2015 Aug 24;9:4873-82. doi: 10.2147/DDDT.S91116. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26346117 Free PMC article.

6

Synthesis and biological activity of acetyl-protected hydroxybenzyl diethyl phosphates (EHBP) as potential chemotherapeutic agents.

Kodela R, Chattopadhyay M, Nath N, Cieciura LZ, Pospishill L, Boring D, Crowell JA, Kashfi K. Kodela R, et al. Bioorg Med Chem Lett. 2011 Dec 1;21(23):7146-50. doi: 10.1016/j.bmcl.2011.09.075. Epub 2011 Sep 22. Bioorg Med Chem Lett. 2011. PMID: 22001089

7

Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo.

Chattopadhyay M, Kodela R, Nath N, Street CR, Velázquez-Martínez CA, Boring D, Kashfi K. Chattopadhyay M, et al. Among authors: kodela r. Biochem Pharmacol. 2012 Mar 15;83(6):733-40. doi: 10.1016/j.bcp.2011.12.020. Epub 2011 Dec 24. Biochem Pharmacol. 2012. PMID: 22209714

8

Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH-naproxen (AVT-219) a dual NO- and H2S-releasing hybrid.

Chattopadhyay M, Kodela R, Duvalsaint PL, Kashfi K. Chattopadhyay M, et al. Among authors: kodela r. Pharmacol Res Perspect. 2016 Mar 4;4(2):e00224. doi: 10.1002/prp2.224. eCollection 2016 Apr. Pharmacol Res Perspect. 2016. PMID: 27069635 Free PMC article.

9

Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury.

Batchu SN, Lee SB, Qadhi RS, Chaudhary KR, El-Sikhry H, Kodela R, Falck JR, Seubert JM. Batchu SN, et al. Among authors: kodela r. Br J Pharmacol. 2011 Feb;162(4):897-907. doi: 10.1111/j.1476-5381.2010.01093.x. Br J Pharmacol. 2011. PMID: 21039415 Free PMC article.

10

NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation.

Chattopadhyay M, Goswami S, Rodes DB, Kodela R, Velazquez CA, Boring D, Crowell JA, Kashfi K. Chattopadhyay M, et al. Among authors: kodela r. Cancer Lett. 2010 Dec 8;298(2):204-11. doi: 10.1016/j.canlet.2010.07.006. Epub 2010 Jul 31. Cancer Lett. 2010. PMID: 20674154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results